CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that Mark Corrigan, President and CEO is scheduled to present at the Rodman and Renshaw Annual Global Healthcare Conference at 4:30pm EDT on September 14, 2010, at the New York Palace Hotel. Interested parties may access a live webcast of the presentation by visiting the Zalicus website at www.zalicus.com or through the provider’s website http://www.wsw.com/webcast/rrshq18/zlcs. The webcast will be archived on the Zalicus website following the event.
